CSF p-tau as a potential cognition impairment biomarker in ALS.

Gong Z, Gao L, Lu Y, Wang Z

DOI: 10.3389/fneur.2022.991143
Published: 2022
Container: Frontiers in neurology
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2022.991143,
  title = {CSF p-tau as a potential cognition impairment biomarker in ALS.},
  author = {Gong Z and Gao L and Lu Y and Wang Z},
  year = {2022},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2022.991143},
  url = {https://doi.org/10.3389/fneur.2022.991143}
}

RIS

TY  - JOUR
TI  - CSF p-tau as a potential cognition impairment biomarker in ALS.
AU  - Gong Z
AU  - Gao L
AU  - Lu Y
AU  - Wang Z
PY  - 2022
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2022.991143
UR  - https://doi.org/10.3389/fneur.2022.991143
ER  -

APA

Z, G., L, G., Y, L., & Z, W. (2022). CSF p-tau as a potential cognition impairment biomarker in ALS.. Frontiers in neurology. https://doi.org/10.3389/fneur.2022.991143

Source records

pubmed · retrieved 2026-09-25T07:49:57.168Z